phase 1_2_completion
saveArvinas Inc — samuraciclib (Phase I/II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Metastatic Breast Cancer